Glycemic Control Reverses Increases in Urinary Excretions of Immunoglobulin G and Ceruloplasmin in Type 2 Diabetic Patients with Normoalbuminuria

T. Narita; H. Fujita; J. Koshimura; H. Meguro; H. Kitazato; T. Shimotomai; E. Kagaya; K. Suzuki; M. Murata; A. Usami; S. Ito

doi:10.1055/s-2001-15415

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2001; 33(6): 370-378
DOI: 10.1055/s-2001-15415

Original Clinical

Glycemic Control Reverses Increases in Urinary Excretions of Immunoglobulin G and Ceruloplasmin in Type 2 Diabetic Patients with Normoalbuminuria

T. Narita ¹ , H. Fujita ¹ , J. Koshimura ¹ , H. Meguro ¹ , H. Kitazato ¹ , T. Shimotomai ¹ , E. Kagaya ² , K. Suzuki ² , M. Murata ³ , A. Usami ⁴ , S. Ito ¹

¹ Division of Geriatric Medicine, Akita University Hospital, Akita, Japan
² First Department of Internal Medicine, Niigata University, Niigata, Japan
³ Division of Internal Medicine, Akita Red Cross Hospital, Akita, Japan
⁴ Division of Internal Medicine, Niigata Saiseikai Daini Hospital, Niigata, Japan

Abstract

To examine whether urinary excretions of plasma proteins with molecular radii of 45 - 55 Å and different isoelectric points such as IgG (pl = 7.4) and ceruloplasmin (pl = 4.4) increase selectively in normoalbuminuric type 2 diabetic patients, urinary albumin excretion rate (AER), renal clearances of IgG, ceruloplasmin and α2-macroglobulin, and creatinine clearance (Ccr) were studied in timed overnight urine samples of 36 diabetic outpatients and 16 control subjects. Furthermore, to examine effect of glycemic control on these urinary protein excretions, the same analysis was performed before and after glycemic control in 17 diabetic inpatients admitted for glycemic control. Renal clearances of IgG and ceruloplasmin were significantly higher in diabetic outpatients than in the control group, whereas AER and renal clearance of α2-macroglobulin did not differ. Glycemic control caused significant decreases in renal clearances of IgG and ceruloplasmin, accompanied with tendency for Ccr to decrease (p = 0.055). The present results, together with our previous finding of selectively increased urinary excretions of 45 - 55 Å sized plasma proteins in parallel with enhanced glomerular filtration rate after acute protein loading, led us to conclude that enhanced intraglomerular hydraulic pressure may cause increases in clearances of IgG and ceruloplasmin, and that this change can be reversed by strict glycemic control in normoalbuminuric diabetic patients.

Key words:

Urinary Protein Excretion - Diabetic Nephropathy - Intraglomerular Hydraulic Pressure

Full Text

References

1 Parving H H, Osterby R, Anderson P, Whsueh W A. Diabetic nephropathy. In: Brenner BM (ed). The Kidney. 5th ed. Philadelphia: ; Saunders, 1996: 1864-1892
2 Nakamura Y, Myers B D. Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes. 1988; 37 1202-1211
3 Pietravalle P, Morano S, Cristina G, De Rossi M G, Mariani G, Cotroneo P, Ghirlanda G, Clementi A, Andreani D, Di Mario U. Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes. 1991; 40 1685-1690
4 Deckert T, Kofoed-Enevoldsen A, Vidal P, Nørgaard K, Andreasen H B, Feldt-Rasmussen B. Size- and charge-selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia. 1993; 36 244-251
5 Morano S, Pietravalle P, De Rossi M G, Mariani G, Cristina G, Medici F, Sensi M, Andreani D, Di Mario U. A charge selectivity impairment in protein permselectivity is present in type 2 diabetes. Acta Diabetol. 1993; 30 138-142
6 Fox J G, Quinn J D, Paterson K R, O’Reilly D StJ, Smith M P, Boulton-Jones J M. Glomerular charge selectivity in type 1 (insulin-dependent) diabetes mellitus. Diabet Med. 1995; 12 387-391
7 Torffvit O, Rippe B. Size and charge selectivity of glomerular filter in patients with insulin-dependent diabetes mellitus: Urinary immunoglobulins and glycosaminoglycans. Nephron. 1999; 83 301-307
8 Myers B D, Winetz J A, Chui F, Michaels A S. Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney Int. 1982; 21 633-641
9 Tomlanovich S, Been W M, Jones HW I II, Schwartz H C, Myers B D. Functional nature of the glomerular injury in progressive diabetic glomerulopathy. Diabetes. 1987; 36 556-565
10 Scandling J D, Myers B D. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int. 1992; 41 840-846
11 Gall M A, Rossing P, Kofoed-Enevoldsen A, Nielsen F S, Parving H H. Glomerular size- and charge-selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1994; 37 195-201
12 Myers B D, Nelson R G, Williams G W, Bennett P H, Hardy S A, Berg R L, Loon N, Knowler W C, Mitch W E. Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent onset. J Clin Invest. 1991; 88 524-530
13 Hostetter T H, Rennke H G, Brenner B M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982; 72 375-380
14 Zatz R, Meyer T W, Rennke H G, Brenner B M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA. 1985; 82 5963-5967
15 Anderson S, Brenner B M. Pathogenesis of diabetic nephropathy: Hemodynamic considerations. Diabetes Metab Rev. 1988; 4 163-177
16 Tencer J, Torflfrit O, Thysell H, Rippe B, Grubb A. Proteinuria selectivity index based upon α2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Kidney Int. 1998; 54 2098-2105
17 Narita T, Koshimura J, Suzuki K, Murata M, Meguro H, Fujita H, Kitazato H, Ito S. Effects of short-term glycemic control, low protein diet and administration of enarapril on renal hemodynamics and protein permselectivity in Type 2 diabetic patients with microalbuminuria. Tohoku J Exp Med. 1999; 189 117-133
18 Anderson S, Vora J P. Current concepts of renal hemodynamics in diabetes. J Diabetes Complications. 1995; 9 304-307
19 Narita T, Kitazato H, Koshimura J, Suzuki K, Murata M, Ito S. Effects of protein meals on the urinary excretion of various plasma proteins in healthy subjects. Nephron. 1999; 81 398-405
20 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20 1183-1195
21 Bertolatus J A, Abuyousef M, Hunsicker L G. Glomerular sieving of high molecular weight proteins in proteinuric rats. Kidney Int. 1987; 31 1257-1266
22 Yamazaki M, Ito S, Usami A, Tani N, Hanyu O, Nakagawa O, Nakamura H, Shibata A. Urinary excretion rate of ceruloplasmin in non-insulin dependent diabetic patients with different stage of nephropathy. Eur J Endocrinol. 1995; 132 681-687
23 Ito S, Usami A, Yamazaki M, Shibata A. A radioimmunometric assay for urinary α2-macroglobulin. Tohoku J Exp Med. 1995; 176 137-147
24 Brodows R G, Nichols D, Shaker G, Kubasik N P. Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care. 1986; 9 189-193
25 Maroni B J, Steinman T I, Mitch W E. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985; 27 58-65
26 Paul A A, Southgate D AT. McCance and Widdowson’s The Composition of Foods, 4th ed. London:; HMSO Books, 1978: 7-8
27 Isaksson B. Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr. 1980; 33 4-5
28 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997; 157 2413-2446
29 American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1998; 21 S23-S31
30 European Diabetes Policy Group. A desktop guideline to Type 2 diabetes mellitus. Diabet Med. 1999; 16 716-730
31 Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 WHO-International Society of Hypertension Guidelines for the management of hypertension. Guidelines Sub-Committee. Clin Exp Hypertens. 1999; 21 1009-1060
32 Ramsay L E, Williams B, Johnston G D, MacGregor G A, Poston L, Potter J F, Poulter N R, Russel G. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999; 13 569-592
33 Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int. 1988; 33 100-106
34 Jerums G, Alien T J, Cooper M E. Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes. Diabetic Med. 1989; 6 772-779
35 Hoogenberg K, Sluiter W J, Navis G, Van Haeften T W, Smit A J, Reitsma W D, Dullaart R PF. Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus. J Am Soc Nephrol. 1998; 9 643-654
36 Fujita H, Narita T, Ito S. Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance. Diabetes Care. 1999; 22 823-826
37 Deen W M, Bridges C R, Brenner B M, Myers B D. Heteroporous model of glomerular size selectivity: Application to normal and nephrotic humans. Am J Physiol. 1985; 249 (Renal Fluid Electrolyte Physiol 18) F374-F389
38 Myers B D. Pathophysiology of proteinuria in immune glomerular injury. Am J Nephrol. 1990; 10 19-23
39 Tencer J, Frick I M, Oqvist B, Aim P, Rippe B. Size selectivity of the glomerular barrier to high molecular weight proteins. The upper size limitation of the shunt pathways. Kidney Int. 1998; 53 709-715
40 Kaysen G A, Myers B D, Couser W G, Rabkin R, Felts J M. Biology of disease. Mechanisms and consequences of proteinuria. Lab Invest. 1986; 54 479-498
41 Ishibashi F. Glomerular clearance and tubular reabsorption of IgGl and IgG4 in microalbuminuric patients with non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Res Clin Prac. 1993; 22 45-51
42 Morelli E, Loon N, Meyer T W, Peters W, Myers B D. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes. 1990; 39 76-82
43 Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G C, Remuzzi G. Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol. 1993; 6 36-43
44 Rosenberg M E, Swanson J E, Thomas B L, Hostetter T H. Glomerular and hormonal response to dietary protein intake in human renal disease. Am J Physiol. 1987; 253 (Renal Fluid Electrolyte Physiol 22) F1083-F1090

T. Narita,M.D.

Division of Geriatric Medicine
Akita University Hospital

1-1-1 Hondo, Akita 010-8543
Japan

Phone: Phone:+ 81 (18) 884-6040

Fax: Fax:+ 81 (18) 884-6449

Email: E-mail:narita@med.akita-u.ac.jp